Skip to main content
. 2021 Jul 20;19:181. doi: 10.1186/s12955-021-01822-9

Table 1.

Demographic and clinical variables according to King’s college stages

Total
(n = 547)
Stage 1
(n = 224)
Stage 2
(n = 193)
Stage 3
(n = 86)
Stage 4
(n = 44)
P value
Age, years (M (SD)) 54.7 (11.4) 54.0 (11.0) 55.1 (11.8) 55.1 (12.7) 55.5 (9.5) 0.796
Male (n, (%)) 347 (63.4) 153 (68.3) 114 (59.1) 52 (60.5) 28 (63.6) 0.240
Education, years (M (SD)) 9.4 (3.6) 9.7 (3.8) 9.1 (3.4) 8.8 (3.4) 9.5 (3.7) 0.081
Age at onset, years (M (SD)) 53.4 (11.4) 52.8 (11.1) 53.8 (11.7) 53.9 (12.6) 53.8 (9.5) 0.865
Disease duration, months (M (SD)) 15.5 (14.4) 15.1 (14.3) 15.2 (14.3) 14.5 (13.2) 20.7 (16.5) 0.049
Diagnostic delay, months (M (SD)) 14.6 (14.0) 14.3 (13.6) 14.3 (14.1) 13.6 (13.1) 20.1 (16.6) 0.034
Onset region (B, UL, LL) 68, 273, 206 30, 109, 85 22, 96, 75 10, 47, 29 6, 21,17 0.967
ALSFRS-R score, (M (SD) 41.4 (4.4) 44.4 (2.4) 40.8 (3.4) 37.6 (4.2) 36.4 (5.1) < 0.001*
BMI, M (SD) 22.6 (3.1) 22.8 (3.1) 22.5 (3.2) 22.5 (3.1) 22.5 (3.2) 0.806

ALSFRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised; B, bulbar onset; UL, upper limb; LL, lower limb; BMI, body mass index; M, mean; SD, standard deviation

*Significant difference. P values were Bonferroni-adjusted